Statements in which the resource exists as a subject.
PredicateObject
rdf:type
entrezgene:pubmed
pubmed-article:10207088, pubmed-article:10225209, pubmed-article:10384093, pubmed-article:10393859, pubmed-article:10400814, pubmed-article:10446807, pubmed-article:10480634, pubmed-article:10580107, pubmed-article:10644332, pubmed-article:10644726, pubmed-article:10671224, pubmed-article:10799874, pubmed-article:11044099, pubmed-article:11160671, pubmed-article:11241736, pubmed-article:11299302, pubmed-article:11385624, pubmed-article:11511100, pubmed-article:11522182, pubmed-article:11579140, pubmed-article:11704662, pubmed-article:11827962, pubmed-article:11833470, pubmed-article:12167619, pubmed-article:12427593, pubmed-article:12473373, pubmed-article:12482669, pubmed-article:12485413, pubmed-article:1505523, pubmed-article:1583734, pubmed-article:7494249, pubmed-article:7690421, pubmed-article:7729429, pubmed-article:7800480, pubmed-article:7838536, pubmed-article:7859743, pubmed-article:8113688, pubmed-article:8207793, pubmed-article:8615004, pubmed-article:8627654, pubmed-article:8676466, pubmed-article:8709193, pubmed-article:8724035, pubmed-article:8834464, pubmed-article:9110146, pubmed-article:9278385, pubmed-article:9510190, pubmed-article:9525916, pubmed-article:9566873, pubmed-article:9730685, pubmed-article:9792375
entrezgene:interactant
entrezgene:geneRifText
Activation of NFkappaB by HIV-1 Tat is inhibited by Nitric Oxide, Activation of NFkappaB by HIV-1 Tat leads to a reduction in adenylyl cyclase activity and an inhibition of cAMP synthesis, HIV-1 Tat activates NFkappaB through the cellular interferon-inducible, double-stranded RNA dependent protein kinase, PKR, HIV-1 Tat activates NFkappaB, causing the induction of CD95 ligand, CD69, iNOS, MCP-1, IL-2, IL-6, IL-8, IL-10, TNF-alpha, VCAM-1, ICAM-1, E-selectin, and MMP-9, as well as monocyte adhesion, cellular activation and angiogenesis, HIV-1 Tat enhances tumor necrosis factor-induced activation of NFkappaB by downregulating manganese-dependent superoxide dismutase (MnSOD), HIV-1 Tat has been shown to bind NFkappaB in vitro in gel shift, GST-pull down and affinity matrix assays, HIV-1 Tat-mediated transcriptional activation of the HIV-1 LTR promoter requires NFkappaB binding sites in the promoter and involves the activation of NFkappaB by Tat, NFAT-1 negatively regulates HIV-1 Tat-mediated transactivation of the HIV-1 LTR by competing with NFkappaB for its binding to the LTR, thereby blocking the interaction of NFkappaB with Tat, NFkappaB tethers the p160 nuclear receptor co-activator GRIP1 to the HIV-1 LTR promoter, thereby regulating the full activation of this promoter by HIV-1 Tat, p56-lck plays a critical role in the activation of NFkappaB by HIV-1 Tat
entrezgene:keyphrase
interacts with, regulated by, binds, activates